
The metabolic reset protocol.
GLP-1-based metabolic support with bloodwork-driven clinical oversight. RESHAPE treats the root cause, not just the symptom.
Who it's for: Adults with metabolic weight challenges, insulin resistance, or documented need for GLP-1 intervention — physician-supervised.
RESHAPE START / RESHAPE PRO is the RESHAPE-aligned protocol. Pick it as your 1 protocol at Foundation, or pair it with additional protocols at Optimizer (2 total) or Elite (3 total).
GLP-1 receptor agonist — entry tier
A synthetic GLP-1 analog, FDA-approved as Wegovy (chronic weight management) and Ozempic (type 2 diabetes). Once-weekly subcutaneous dosing. Suppresses appetite at the hypothalamus, slows gastric emptying, and supports glucose-dependent insulin secretion.
Dual GIP / GLP-1 receptor agonist — advanced tier
A dual-mechanism agonist of both GLP-1 and GIP receptors. FDA-approved as Mounjaro and Zepbound. Demonstrated 20%+ mean body-weight reduction in qualifying clinical-trial populations — a meaningful step beyond GLP-1 monotherapy.
The following reflects areas of interest commonly reported by members and studied in the clinical literature. Results depend on individual health status, labs, and physician-directed care. Nothing below constitutes a treatment claim.
GLP-1 receptor agonists like semaglutide and tirzepatide work by mimicking gut hormones that signal fullness to the brain. They are FDA-approved medications for chronic weight management in qualifying individuals, as determined by a physician.
GLP-1 medications were originally developed for type 2 diabetes management. They improve insulin sensitivity and reduce post-meal glucose spikes — both important markers tracked in the RESHAPE bloodwork panel.
Clinical trials with GLP-1 medications have shown favorable effects on cardiovascular risk markers in certain populations. Your lipid panel and metabolic markers are monitored throughout the protocol to track progress objectively.
RESHAPE is not a standalone prescription service. Every member's protocol is built on bloodwork data — including fasting insulin and HbA1c — so the clinical approach addresses the underlying metabolic picture, not just the number on the scale.
Every protocol begins with comprehensive labs. No prescription is issued without data.

"Your biology has a halftime.
This is the strategy session."
Starting at $199/mo
Pick any of the 12 protocols (5 base + 7 standard peptide) at any tier. Premium add-ons (VITALIZE, IMMUNE GUARD, MITOCORE) bill separately on top of any tier with clinical gating. The Halftime Baseline bloodwork panel ($249) is a separate onboarding deliverable, available at any tier.
Join the waitlistLaunching July 1, 2026
All prescriptions require physician evaluation. Compounded medications are not FDA-approved. Individual results vary. This is not medical advice.